Evidence map›Paper›PMID 32069299›Full record

ArticlePloS one2020

Novel CYP4F22 mutations associated with autosomal recessive congenital ichthyosis (ARCI). Study of the CYP4F22 c.1303C>T founder mutation.

Uxia Esperón-Moldes, Manuel Ginarte-Val, Laura Rodríguez-Pazos, Laura Fachal, Ana Martín-Santiago, Asunción Vicente, David Jiménez-Gallo, Encarna Guillén-Navarro, Loreto Martorell Sampol, María Antonia González-Enseñat and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Human genetic defects of sphingolipid synthesis.Journal of inherited metabolic disease · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Human Orphan Cytochromes P450: An Update.Current drug metabolism · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Uxia Esperón-MoldesFundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain.
Manuel Ginarte-ValDermatology Service of Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.ORCID 0000-0002-7030-7484
Laura Rodríguez-PazosDermatology Service of Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
Laura FachalFundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain.
Ana Martín-SantiagoDermatology Service of Hospital Universitari Son Espases, Palma de Mallorca, Spain.
Asunción VicenteDermatology Service of Hospital Sant Joan de Déu, Barcelona, Spain.
David Jiménez-GalloDermatology Service of Hospital Puerta del Mar, Cádiz, Spain.
Encarna Guillén-NavarroDermatology Service of Hospital clínico universitario Virgen de la Arrixaca, Murcia, Spain.
Loreto Martorell SampolGenetic Service of Hospital Sant Joan de Déu, Barcelona, Spain.
María Antonia González-EnseñatDermatology Service of Hospital Sant Joan de Déu, Barcelona, Spain.
Ana VegaFundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain.ORCID 0000-0002-7416-5137
Hospital Sant Joan de Déu Barcelona · ESFundación Pública Galega de Medicina Xenómica · ESComplejo Hospitalario Universitario de Santiago · ESHospital Universitario Puerta del Mar · ESHospital Universitario Son Espases · ESHospital Universitario Virgen de la Arrixaca · ESUniversidade de Santiago de Compostela · ESUniversity Hospital Complex Of Vigo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in CYP4F22 cause autosomal recessive congenital ichthyosis (ARCI). However, less than 10% of all ARCI patients carry a mutation in CYP4F22. In order to identify the molecular basis of ARCI among our patients (a cohort of ninety-two Spanish individuals) we performed a mutational analysis using direct Sanger sequencing in combination with a multigene targeted NGS panel. From these, eight ARCI families (three of them with Moroccan origin) were found to carry five different CYP4F22 mutations, of which two were novel. Computational analysis showed that the mutations found were present in highly conserved residues of the protein and may affect its structure and function. Seven of the eight families were carriers of a highly recurrent CYP4F22 variant, c.1303C>T; p.(His435Tyr). A 12Mb haplotype was reconstructed in all c.1303C>T carriers by genotyping ten microsatellite markers flanking the CYP4F22 gene. A prevalent 2.52Mb haplotype was observed among Spanish carrier patients suggesting a recent common ancestor. A smaller core haplotype of 1.2Mb was shared by Spanish and Moroccan families. Different approaches were applied to estimate the time to the most recent common ancestor (TMRCA) of carrier patients with Spanish origin. The age of the mutation was calculated by using DMLE and BDMC2. The algorithms estimated that the c.1303C>T variant arose approximately 2925 to 4925 years ago, while Spanish carrier families derived from a common ancestor who lived in the XIII century. The present study reports five CYP4F22 mutations, two of them novel, increasing the number of CYP4F22 mutations currently listed. Additionally, our results suggest that the recurrent c.1303C>T change has a founder effect in Spanish population and c.1303C>T carrier families originated from a single ancestor with probable African ancestry.

Indexed as

Founder EffectGenes, RecessiveMutationAllelesAmino Acid SubstitutionChildChild, PreschoolCytochrome P-450 Enzyme SystemFemaleHaplotypesHumansIchthyosis, LamellarMaleMiddle AgedModels, MolecularPedigreeCYP4F22 protein, humanCytochrome P-450 Enzyme System

Identifiers

PMID32069299
PMCPMC7028276
OpenAlexW3008391747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.